New Delhi: Cadila Healthcare Ltd Managing Director Sharvil Pankajbhai Patel on Saturday explained the drugmaker’s plans to start the dosage of ZyCOV-D vaccine after getting approval for the same.
The Drug Controller General of India on Friday had approved emergency use for ZyCoV-D, the COVID-19 vaccine by Zydus Cadila, the world’s first DNA shot against coronavirus.
Read also | Zydus Cadila’s ZyCov-D: All About the World’s First DNA Vaccine for COVID | 10 points
“Next week (we) will have clarity on the price of ZyCOV-D vaccine. The supply of vaccines will start in mid-September. We can increase the production of vaccines to 1 crore per month from October at the new production plant, Zydus Group MD Dr. Sharvil Patel is quoted by news agency ANI.
The efficacy of our COVID-19 vaccine is over 66 per cent, and its efficacy against the delta variant is around 66 per cent, he said.
The world’s first DNA-based vaccine for COVID-19 was approved to be administered to adults and children 12 years of age and older.
ZyCoV-D . About this
The vaccine has been developed under ‘Mission COVID Suraksha’ in partnership with the Department of Biotechnology, Government of India and implemented by the Biotechnology Industry Research Assistance Council (BIRAC).
This three-dose vaccine, when injected, produces the spike protein of the SARS-CoV-2 virus and elicits an immune response that plays an important role in protection against disease as well as viral clearance.
The Department of Biotechnology, under the Ministry of Science and Technology, informed, “The plug-and-play technology on which the plasmid DNA platform is based can be easily adapted to deal with mutations in viruses, such as those already existing. Used to be.”
While most COVID vaccines require two doses or even a single dose, ZyCoV-D will be given in three doses – the first on day 0, the second on day 28 and the last on day 56.
The company had earlier said that it also has a needle-free application system unlike conventional syringes.
ZyCoV-D is the sixth vaccine authorized for emergency use in India and the second indigenous COVID vaccine after Bharat Biotech’s Covaxin.
Earlier, the company also revealed that it is working on a two-dose vaccine.
See below health equipment-
Calculate your body mass index (BMI)
.